The new Hepatitis C drug Gizumab, which is referred to as sofosbuvir vipatasvir tablets, costs between $3,000 and $5,000 for a box of 28 tablets, and the exact pricing can be found in your local hospital. Sofosbuvir vipatasvir tablets is a combination preparation made of sofosbuvir and vipatasvir, which has an anti-chronic hepatitis C virus effect and is suitable for the treatment of chronic hepatitis C virus infection in adults. The price of the drug is not standardized, due to the influence of manufacturers, distribution platforms, distribution areas and other aspects of the specifications of 28 tablets / box of the drug price is generally between 3,000 to 5,000 yuan. Contraindications to the use of the drug include hypersensitivity to the product, and contraindicated with potent P-glycoprotein inducers, potent cytochrome P450 inducers (such as rifampicin, carbamazepine, phenobarbital, etc.). The most common adverse reactions following administration include headache, fatigue, and nausea. Specific medications should be administered under the direction of a physician, after completing relevant examinations, and in accordance with the indications for medication.